RxDoctor Payments Data

Rebecca Romine, APRN

Family · Butte, MTNPI 1033737820

Payments from drug & device makers

$278in general payments, 2019–2025

Across 15 payments — averaging $18.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$58
  • Novo Nordisk$36
  • Exact Sciences$33
  • AstraZeneca$27
  • Abiomed$23
  • Inspire Medical Systems, Inc.$20
  • plus $81 from 5 others

What the payments were for

  • Food & beverage$278100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$278 in reported general payments places this provider in the 65th percentile of 481 family providers in Montana.

See all family providers in Montana

Medicare billing

Part B allowed, 2024
$25,072
Medicare patients
158
Services billed
844

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin82$58,732
TrulicityDulaglutide53$58,140
OzempicSemaglutide56$54,089
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$31,694
EliquisApixaban37$28,545
XareltoRivaroxaban30$22,742
Spiriva HandihalerTiotropium Bromide26$19,627
Spiriva RespimatTiotropium Bromide22$15,607
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr33$15,065
Incruse ElliptaUmeclidinium Bromide33$13,876
SymbicortBudesonide/Formoterol Fumarate19$6,076
Advair HfaFluticasone Propion/Salmeterol15$5,035
Fluticasone-SalmeterolFluticasone Propion/Salmeterol29$4,715
Breo ElliptaFluticasone/Vilanterol12$4,707
Albuterol Sulfate HfaAlbuterol Sulfate115$4,253

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat$17$74,338104 claims
Novo NordiskOzempic$36$54,08956 claims
AstraZenecaSymbicort$27$6,07619 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 481 family providers in Montana.

Other family in Butte

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →